Experts lament lack of informed public debate on bioterrorismDecember 11, 2001Some misleading media reports about the threat from bioterrorism may be increasing the risk of widespread panic if an attack was to occur, a leading expert will warn at an open public meeting today (12 November). Scientists and journalists must work together to ensure that the public has an accurate understanding of the effects of biological agents such as anthrax, according to Professor Harry Smith, Emeritus Professor of Microbiology at Birmingham University, who chaired last year’s Royal Society study on biological weapons. Professor Smith will be speaking about ‘Bioterorism: facts and fictions’ at a public meeting organised by the BA (British Association for the Advancement of Science) and the Royal Society. He will be joined by Dr Patricia Troop, Deputy Chief Medical Officer for England, and Professor Malcolm Dando, Professor of International Security at the University of Bradford. Commenting on the UK’s readiness to deal with a bioterrorism attack Dr Troop will say: “The UK has in place robust plans to deal with emergencies including biological terrorism. These have been extensively revised and reviewed since the events of the 11th September. A wide range of guidance has been made available to the field. In addition, recognising that this is an international problem, we have been working with colleagues in the US and Europe to ensure this is a truly international response.” Meanwhile Professor Dando, will argue for a multifaceted ‘web of deterrence’ to prevent the development and use of biological weapons. However, he does not see that this can easily be achieved without a great deal more public understanding and political effort than is evident at the moment. Professor Smith will go on to add that the risk from biological agents must be realistically assessed in light of recent anthrax attacks in the US: “As we have seen with the recent anthrax attacks, biological weapons are not proven to cause a large number of casualties, but still represent a wider threat through the panic that they can cause within the population. If the effects of biological agents are exaggerated beforehand, it is very likely that people will panic, regardless of whether they are directly affected. Therefore, it is essential that members of the public are provided with enough accurate information so that they can respond appropriately to the threat of bioterrorism.” In contrast, Professor Dando believes that the threat from bioterrorism is greater than ever before: “I regarded effective biological terrorism causing mass casualties as a low risk before September 11th. There were two reasons. I thought that it was unlikely that any terrorist would have political reasons for wishing to cause mass casualties (moral constraint), and I thought it would be very difficult to do anyway (technical constraint). “After September 11th it is not sensible to assume that the moral constraint still exists, however the technical constraint still does exist. The evidence we have from the major State offensive biological weapons programmes over the last century demonstrates that it is possible to use biological weapons to kill very large numbers of people, but that an enormous effort was required to achieve this capability. Our real problem today is that the biotechnology revolution is spreading a mechanistic biology around the world at a great pace and this may give malign people much easier ways to obtain effective biological weapons at precisely the time when asymmetric means of warfare are becoming more attractive because of the West`s overwhelming conventional/nuclear superiority in conventional and nuclear weapons.” British Association for the Advancement of Science (The BA) |
|||||||||||||||||||||
| Related Anthrax Current Events and Anthrax News Articles Milestone biodefense publication by Elsevier journal Vaccine Last week during the 'Vaccines for Biothreats and Emerging and Neglected Diseases Symposium' in Galveston TX, USA, the Elsevier journal Vaccine released a supplement dedicated to vaccines for biodefense. Cigarettes Harbor Many Bacteria Harmful to Human Health Cigarettes are "widely contaminated" with bacteria, including some known to cause disease in people, concludes a new international study conducted by a University of Maryland environmental health researcher and microbial ecologists at the Ecole Centrale de Lyon in France. New explanation for nature's hardiest life form Got food poisoning? The cause might be bacterial spores, en extremely hardy survival form of bacteria, a nightmare for health care and the food industry and an enigma for scientists. Better immune defense against anthrax Scientists discover a gene in anthrax-causing bacteria may help defend against this form of bio-warfare. Argonne researchers develop method that aims to stabilize antibodies Researchers at the U.S. Department of Energy's Argonne National Laboratory have developed a systematic method to improve the stability of antibodies. Early detection and quick response are key to defense against anthrax attack A large attack on a major metropolitan area with airborne anthrax could affect more than a million people, necessitating their treatment with powerful antibiotics. Data published in the New England Journal of Medicine support use of raxibacumab (ABthrax) for the treatment of inhalation anthrax Human Genome Sciences, Inc. (Nasdaq: HGSI) today announced publication by the New England Journal of Medicine of the results of two pivotal animal efficacy studies, which showed the life-saving potential of the Company's human monoclonal antibody drug raxibacumab. One secret to how TB sticks with you Mycobacterium tuberculosis is arguably the world's most successful infectious agent because it knows how to avoid elimination by slowing its own growth to a crawl. Unexpected discovery can open a new chapter in the fight against tuberculosis A close relative of the microorganism that causes tuberculosis in humans has been found to form spores. Genetic switch potential key to new class of antibiotics Researchers have determined the structure of a key genetic mechanism at work in bacteria, including some that are deadly to humans, in an important step toward the design of a new class of antibiotics. More Anthrax Current Events and Anthrax News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||